Screener
Gilead Sciences GILD Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
FAQ
- What is Gilead Sciences's free cash flow?
- Gilead Sciences (GILD) reported free cash flow of $3.43B in Q2 2026.
- How has Gilead Sciences's free cash flow changed year-over-year?
- Gilead Sciences's free cash flow increased by 376.8% year-over-year, from $720M to $3.43B.
- What is the long-term trend for Gilead Sciences's free cash flow?
- Over 4 years (2021 to 2025), Gilead Sciences's free cash flow has grown at a -3.3% compound annual growth rate (CAGR), from $10.81B to $9.46B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Gilead Sciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude